These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 25099447

  • 1. Hepatobiliary cancers, version 2.2014.
    Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H.
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 4. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A, Wittekind C.
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J.
    ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
    [Abstract] [Full Text] [Related]

  • 7. Biliary tract cancer.
    Curley SA.
    Cancer Treat Res; 1997 Dec; 90():273-307. PubMed ID: 9367089
    [No Abstract] [Full Text] [Related]

  • 8. [Tumor grading of the hepatobiliary system].
    Jütte H, Tannapfel A.
    Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
    Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, Hawkins WG, Iyer R, Jacob R, Jennings L, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Ronnekleiv-Kelly S, Sahai V, Singh G, Stein S, Turk A, Vauthey JN, Venook AP, Yopp A, McMillian N, Schonfeld R, Hochstetler C.
    J Natl Compr Canc Netw; 2023 Jul; 21(7):694-704. PubMed ID: 37433432
    [Abstract] [Full Text] [Related]

  • 11. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
    Friend E, Yadegarfar G, Byrne C, Johnson CD, Sezer O, Pucciarelli S, Pereira SP, Chie WC, Banfield A, Ramage JK, EORTC Quality of Life Group.
    Br J Cancer; 2011 Feb 15; 104(4):587-92. PubMed ID: 21266979
    [Abstract] [Full Text] [Related]

  • 12. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
    Floreani A, Lisiero M, Baldovin T, Baldo V.
    Eur J Gastroenterol Hepatol; 2013 Nov 15; 25(11):1347-51. PubMed ID: 24081106
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.
    Semin Liver Dis; 2011 Feb 15; 31(1):49-60. PubMed ID: 21344350
    [Abstract] [Full Text] [Related]

  • 14. [Clinical, epidemiological and therapeutic features of biliary tract cancers: about 20 cases].
    Ka I, Faye M, Diop PS, Faye ABNAC, Ndoye JM, Fall B.
    Pan Afr Med J; 2018 Feb 15; 29():13. PubMed ID: 29662598
    [Abstract] [Full Text] [Related]

  • 15. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
    Surrey LF, Frank R, Zhang PJ, Furth EE.
    Am J Surg Pathol; 2014 Feb 15; 38(2):224-7. PubMed ID: 24418856
    [Abstract] [Full Text] [Related]

  • 16. [Surgery of hepatobiliary tumors].
    Bork U, Koch M, Büchler MW, Weitz J.
    Chirurg; 2010 Feb 15; 81(2):111-16. PubMed ID: 20076936
    [Abstract] [Full Text] [Related]

  • 17. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic Cholangiocarcinoma.
    El-Diwany R, Pawlik TM, Ejaz A.
    Surg Oncol Clin N Am; 2019 Oct 01; 28(4):587-599. PubMed ID: 31472907
    [Abstract] [Full Text] [Related]

  • 19. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M, Nakanuma Y, Ho SB, Kim YS.
    Am J Clin Pathol; 1998 Mar 01; 109(3):302-8. PubMed ID: 9495202
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.